278 results on '"Salari Keyan"'
Search Results
2. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses
3. Magnetic Resonance Imaging–based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study
4. Incorporating Genetic Risk Into Prostate Cancer Care: Implications for Early Detection and Precision Oncology
5. Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus
6. Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond
7. Novel and Investigational Diagnostics: Liquid Biopsy and Beyond
8. MP31-13 CLINICOPATHOLOGICAL DIFFERENCES BETWEEN ANTERIORLY LOCATED AND PERIPHERAL ZONE PROSTATIC LESIONS DETECTED ON PROSTATE MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING
9. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer
10. CONDITIONAL SURVIVAL IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
11. CHATGPT USE IN PATIENT AND TRAINEE EDUCATION FOR RENAL MASSES AND RENAL CELL CARCINOMA
12. INTENSIFIED MRI-BASED PROSTATE CANCER SCREENING IN GERMLINE CARRIERS OF RARE PATHOGENIC VARIANTS: INTERIM RESULTS FROM THE INITIAL SCREENING ROUND OF THE PROGRESS STUDY
13. DETECTION, RISK STRATIFICATION, AND THERAPUETIC SELECTION FOR UPPER TRACT UROTHELIAL CARCINOMA WITH URINE-BASED COMPREHENSIVE GENOMIC PROFILING
14. Biologically informed deep neural network for prostate cancer discovery
15. Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer
16. Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy
17. Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer
18. Transcriptional mediators of treatment resistance in lethal prostate cancer
19. Supplementary Figure 2 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
20. Data from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
21. Supplementary Figure 1 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
22. Supplementary Tables 1-8 from Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
23. Integrative genomic and functional profiling of the pancreatic cancer genome
24. Development and Multicenter Case–Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
25. Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer
26. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
27. PD46-07 URINARY COMPREHENSIVE GENOMIC PROFILING AIDS IN DETECTION AND RISK PROGNOSIS OF UPPER TRACT UROTHELIAL CARCINOMA: A CASE-CONTROLLED COHORT STUDY
28. MP40-12 INTENSIFIED PROSTATE CANCER SCREENING IN GERMLINE CARRIERS OF RARE PATHOGENIC VARIANTS: INTERIM RESULTS FROM THE INITIAL SCREENING ROUND OF THE PROGRESS STUDY
29. MP22-19 URINARY COMPREHENSIVE GENOMIC PROFILING PREDICTS UROTHELIAL CANCER UP TO 12 YEARS AHEAD OF CLINICAL DIAGNOSIS. AN EXPANDED ANALYSIS OF THE GOLESTAN COHORT STUDY
30. Supplementary Figures 1-3 from Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer
31. Data from Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
32. Data from Molecular Inversion Probe Analysis of Gene Copy Alterations Reveals Distinct Categories of Colorectal Carcinoma
33. Data from Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer
34. Supplementary Tables 1-6 from Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer
35. Supplementary Figure 1 from Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
36. Supplementary Data 1 from Molecular Inversion Probe Analysis of Gene Copy Alterations Reveals Distinct Categories of Colorectal Carcinoma
37. Supplementary Figure Legends 1-3 from Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer
38. Supplementary Figure 2 from Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
39. Supplementary Table 1 from Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
40. Analysis of evolutionary dynamics and clonal architecture in prostate cancer
41. Integrating artificial intelligence in renal cell carcinoma: evaluating ChatGPT’s performance in educating patients and trainees
42. Prostate cancer single-cell and spatial transcriptomic data analyses
43. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α‐reductase 2
44. Key Notes on Pembrolizumab and Docetaxel Combination Therapy for Metastatic Castration-Resistant Prostate Cancer
45. CDX2 is an amplified lineage-survival oncogene in colorectal cancer
46. MP43-10 IMPACT OF FAMILY HISTORY AND GERMLINE GENETIC RISK VARIANTS ON LONG-TERM OUTCOMES OF ACTIVE SURVEILLANCE-ELIGIBLE PROSTATE CANCER
47. MP54-08 URINARY COMPREHENSIVE GENOMIC PROFILING PREDICTS CLINICAL RECURRENCE IN PATIENTS UNDERGOING SURVEILLANCE FOR UROTHELIAL CARCINOMA
48. Integrated single-cell and spatial transcriptomic analyses unravel the heterogeneity of the prostate tumor microenvironment
49. A machine learning approach to predict progression on active surveillance for prostate cancer
50. Comprehensive genomic profiling of urine DNA for urothelial carcinoma detection and risk prediction.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.